JP Morgan Chase’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.81M | Buy |
|
|||||
|
2025
Q2 | $2.32M | Buy |
|
|||||
|
2025
Q1 | $2.29M | Sell |
|
|||||
|
2024
Q4 | $2.26M | Buy |
|
|||||
|
2024
Q3 | $197K | Buy |
|
|||||
|
2024
Q2 | $130K | Buy |
|
|||||
|
2024
Q1 | $42.7K | Sell |
|
|||||
|
2023
Q4 | $380K | Buy |
|
|||||
|
2023
Q3 | $13.5K | Hold |
|
|||||
|
2023
Q2 | $13.9K | Sell |
|
|||||
|
2023
Q1 | $16K | Buy |
|
|||||
|
2022
Q4 | $14K | Hold |
|
|||||
|
2022
Q3 | $14K | Sell |
|
|||||
|
2022
Q2 | $4.38M | Buy |
|
|||||
|
2022
Q1 | $2.73M | Buy |
|
|||||
|
2021
Q4 | $1.28M | Buy |
|
|||||
|
2021
Q3 | $206K | Sell |
|
|||||
|
2021
Q2 | $1.76M | Sell |
|
|||||
|
2021
Q1 | $4.29M | Sell |
|
|||||
|
2020
Q4 | $15.5M | Sell |
|
|||||
|
2020
Q3 | $14.1M | Sell |
|
|||||
|
2020
Q2 | $17.6M | Sell |
|
|||||
|
2020
Q1 | $21.2M | Buy |
|
|||||
|
2019
Q4 | $6K | Sell |
|
|||||
|
2019
Q3 | $40.1M | Buy |
|
|||||
|
2019
Q2 | $13.8M | Buy |
|
|||||
|
2019
Q1 | $4.17M | Sell |
|
|||||
|
2018
Q4 | $8.72M | Buy |
|
|||||
|
2018
Q3 | $5.78M | Buy |
|
|||||
|
2018
Q2 | $205K | Sell |
|
|||||
|
2018
Q1 | $313K | Sell |
|
|||||
|
2017
Q4 | $800K | Sell |
|
|||||
|
2017
Q3 | $4.29M | Buy |
|
|||||
|
2017
Q2 | $381K | Sell |
|
|||||
|
2017
Q1 | $1.24M | Buy |
|
|||||
|
2016
Q4 | $765K | Buy |
|
|||||
|
2016
Q3 | $809K | Buy |
|
|||||
|
2016
Q2 | $747K | Buy |
|
|||||
|
2016
Q1 | $528K | Buy |
|
|||||
|
2015
Q4 | $669K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $623K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $464K | Buy |
|